Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2025-05-30
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Toothpastes on Oral Malodor
NCT07329062
The Effect of Oral Care on Mucositis and Oral Mucosa According to Individual Oral Care Frequency Assessment
NCT06521112
Evaluation of Clinical and Cost-effectiveness of Different Mouthwashes on Controlling Halitosis Among a Group of Egyptian Children
NCT04905940
Evaluation of the Effects of Probiotic Toothpastes on Periodontal Health
NCT06514664
The Effect of Pre-operative Single Dose Antibiotic Prophylaxis on the Post-operative Implant Success
NCT04856319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DENEY GRUBU
Oral care training will be given to 40 randomly selected patients and their oral health will then be evaluated.
Mouth Care Training
Patients will be educated on how to care for their mouths after using inhaled medication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mouth Care Training
Patients will be educated on how to care for their mouths after using inhaled medication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient and inpatient,
* Consent to participate in the research,
* Not under the age of eighteen,
* With a metered dose inhaler (MDI) in treatment,
* No communication barriers,
* No COPD exacerbation and/or respiratory tract infection,
* According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).
Exclusion Criteria
* Refused to participate in the research,
* Treatment without metered dose inhalers (MDIs),
* Uncommunicative,
* Those who withdrew from participating in the study during data collection,
* Not completing the survey,
* COPD exacerbation and/or respiratory tract infection,
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Çankırı Karatekin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Betül YALÇIN
NURSE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Betül Yalçın, 2
Role: PRINCIPAL_INVESTIGATOR
Çankırı Karatekin University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Çankiri Devlet Hastanesi
Çankırı, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-07-2024-15-COPD01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.